http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2206124-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44c713790ce00813da2e6c6d57a29456 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-40 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-38 |
| filingDate | 1995-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43e80b4d5122541497ab9d7be4bdc77b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f906db867d3e73de1e05367db49ac8d4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cf86e61250e28f38eecbd2acfd2b96b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1162749f3a47d69cfc75d610a29cf8f7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07ee646f5d3c6d7d2f57a82277aedae8 |
| publicationDate | 1996-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2206124-A1 |
| titleOfInvention | Pyridine derivative |
| abstract | Pyridine derivatives represented by general formula (I) or salts thereof are expected to act on neurons in vivo directly or indirectly to exhibit the effects of ameliorating and curing neuropathy accompanying nerve degeneration. In said formula, R1 represents methyl or any of the functional groups represented by the following formulae: -CONHCH2CH2N(CH3)2, -CONHCH2CH2CH2N(CH3)2, -COOCH2CH2N(CH3)2, -COOCH2CH2N(CH2CH3)2, -NHCOCH2N(CH3)2, -NHCOCH2N(CH2CH3)2, and R2 represents hydrogen, amino or any of the functional groups represented by the following formulae: -CONHCH2CH2N(CH3)2, (b), -COOCH2CH2N(CH3)2, -NHCOCH2H(CH3)2, -NHCOCH2N(CH2CH3)2. For example, they can be used as ameliorants and remedies for symptoms and diseases accompanying traumatic, drug-induced (by, e.g., alcohol or antineoplastic agent), inflammatory, metabolic (as observed in, e.g., diabetes), and idiopathic peripheral nerve degenerations. They are also usable as ameliorants and remedies for symptoms and diseases accompanying central nerve degeneration, for example, senile dementia of Alzheimer type, cerebrovascular dementia, Down's syndrome, Parkinson's disease, Huntington's chorea, sequelae of cerebral ischemia, cerebral infarction, cerebral hemorrhage and head injury, amnesia and spinal neuroparalysis. |
| priorityDate | 1994-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 185.